UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives

Frontiers in cell and developmental biology, 2020-01, Vol.7, p.363-363

2020

Volltextzugriff (PDF)

Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5915

2024

Volltextzugriff (PDF)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16346

2023

Volltextzugriff (PDF)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy

Clinical cancer research, 2018-08, Vol.24 (15), p.3704-3716

2018

Volltextzugriff (PDF)

Novel Regulators of the IGF System in Cancer

Biomolecules (Basel, Switzerland), 2021-02, Vol.11 (2), p.273

2021

Volltextzugriff (PDF)

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers

Cancers, 2022-11, Vol.14 (21), p.5411

2022

Volltextzugriff (PDF)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options

Cells (Basel, Switzerland), 2021-08, Vol.10 (8), p.2075

2021

Volltextzugriff (PDF)

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1588

2024

Volltextzugriff (PDF)

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer

PloS one, 2015-05, Vol.10 (5), p.e0125576-e0125576

2015

Volltextzugriff (PDF)

Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma

Frontiers in oncology, 2022-10, Vol.12, p.968884-968884

2022

Volltextzugriff (PDF)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis

Frontiers in oncology, 2020-07, Vol.10, p.994-994

2020

Volltextzugriff (PDF)

Editorial: RNA-binding proteins in cancer: advances in translational research

Frontiers in cell and developmental biology, 2024, Vol.12, p.1390044-1390044

2024

Volltextzugriff (PDF)

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

PloS one, 2013-12, Vol.8 (12), p.e83832-e83832

2013

Volltextzugriff (PDF)

Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma

Molecular endocrinology (Baltimore, Md.), 2012-09, Vol.26 (9), p.1603-1616

2012

Volltextzugriff (PDF)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R

Frontiers in endocrinology (Lausanne), 2018-04, Vol.9, p.178-178

2018

Volltextzugriff (PDF)

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Cellular oncology (Dordrecht), 2022-12, Vol.45 (6), p.1253-1253

2022

Volltextzugriff (PDF)

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Cellular oncology (Dordrecht), 2022-12, Vol.45 (6), p.1237-1251

2022

Volltextzugriff (PDF)

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status

BMC cancer, 2017-05, Vol.17 (1), p.367-367, Article 367

2017

Volltextzugriff (PDF)

IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy

Journal of molecular endocrinology, 2018-07, Vol.61 (1), p.T45-T60

2018

Volltextzugriff (PDF)

40 YEARS OF IGF1: IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy

Journal of molecular endocrinology, 2018-07, Vol.61 (1), p.T45-T60

2018

Volltextzugriff (PDF)

Abstract 3672: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3-mediated regulation of CD164-CXCR4 axis impacts aggressiveness of Ewing sarcoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3672-3672

2019

Volltextzugriff (PDF)

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells

Cancer gene therapy, 2023-09, Vol.30 (9), p.1285-1295

2023

Volltextzugriff (PDF)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4), p.708-720

2022

Volltextzugriff (PDF)

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy

The Journal of urology, 2014-07, Vol.192 (1), p.252-259

2014

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)
Berichte
(1)

Sprache

Englisch
(54)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives

Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy

Novel Regulators of the IGF System in Cancer

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer

Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis

Editorial: RNA-binding proteins in cancer: advances in translational research

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status

IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy

40 YEARS OF IGF1: IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy

Abstract 3672: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3-mediated regulation of CD164-CXCR4 axis impacts aggressiveness of Ewing sarcoma

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy

Suchergebnisse filtern